G22003AJ
RES 1b:o-dglc-HEX-0:0|1:aldi 2s:phosphate 3s:anhydro LIN 1:1o(6+1)2n 2:1d(1+1)3n 3:1o(5+1)3n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 39283600 | A Widespread Radical-Mediated Glycolysis Pathway | Ma K | 2024 Sep 16 |
|
| 38355710 | Blood cytopenias as manifestations of inherited metabolic diseases: a narrative review | Moutapam-Ngamby-Adriaansen Y | 2024 Feb 14 |
|
| 38376672 | [Diagnosis and management of glycogen storage diseases] | May P | 2024 Feb |
|
| 39630167 | Molecular and Clinical Characterization of a Founder Mutation Causing G6PC3 Deficiency | Zhen X | 2024 Dec 04 |
|
| 38635113 | Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic Review | Lava SAG | 2024 Apr 18 |
|
| 38605407 | Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective study | Shao YX | 2024 Apr 11 |
|
| 37789059 | Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards | Uhlig HH | 2023 Oct 03 |
|
| 37383953 | Elucidation of intermolecular interactions between chlorogenic acid and glucose-6-phosphate translocase: A step towards chemically induced glycogen storage disease type 1b model | Patil SB | 2023 Jun 26 |
|
| 38044448 | Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes | Liu J | 2023 Dec 04 |
|
| 37594549 | SGLT5 is the renal transporter for 1,5-anhydroglucitol, a major player in two rare forms of neutropenia | Diederich J | 2023 Aug 18 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025